1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America Aquaculture Vaccines Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America Aquaculture Vaccines Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America Aquaculture Vaccines Market Regional Analysis
6.2 North America Aquaculture Vaccines Market Revenue 2020-2028 (US$ Million)
6.3 North America Aquaculture Vaccines Market Forecast Analysis
7. North America Aquaculture Vaccines Market Analysis – by Type of Vaccine
7.1 Live Vaccine
- 7.1.1 Overview
- 7.1.2 Live Vaccine: North America Aquaculture Vaccines Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.2 Inactivated Vaccine
- 7.2.1 Overview
- 7.2.2 Inactivated Vaccine: North America Aquaculture Vaccines Market – Revenue and Forecast, 2020-2028 (US$ Million)
8. North America Aquaculture Vaccines Market Analysis – by Species
8.1 Tilapia
- 8.1.1 Overview
- 8.1.2 Tilapia: North America Aquaculture Vaccines Market – Revenue and Forecast, 2020-2028 (US$ Million)
8.2 Trout
- 8.2.1 Overview
- 8.2.2 Trout: North America Aquaculture Vaccines Market – Revenue and Forecast, 2020-2028 (US$ Million)
8.3 Salmon
- 8.3.1 Overview
- 8.3.2 Salmon: North America Aquaculture Vaccines Market – Revenue and Forecast, 2020-2028 (US$ Million)
8.4 Shrimps
- 8.4.1 Overview
- 8.4.2 Shrimps: North America Aquaculture Vaccines Market – Revenue and Forecast, 2020-2028 (US$ Million)
9. North America Aquaculture Vaccines Market Analysis – by Route of Administration
9.1 Injection Vaccines
- 9.1.1 Overview
- 9.1.2 Injection Vaccines: North America Aquaculture Vaccines Market – Revenue and Forecast, 2020-2028 (US$ Million)
9.2 Immersion Vaccines
- 9.2.1 Overview
- 9.2.2 Immersion Vaccines: North America Aquaculture Vaccines Market – Revenue and Forecast, 2020-2028 (US$ Million)
9.3 Oral Vaccines
- 9.3.1 Overview
- 9.3.2 Oral Vaccines : North America Aquaculture Vaccines Market – Revenue and Forecast, 2020-2028 (US$ Million)
10. North America Aquaculture Vaccines Market – North America Analysis
10.1 Overview
10.2 North America
- 10.2.1 North America Aquaculture Vaccines Market Breakdown, by Key
Country, 2023 and 2028 (%)
- 10.2.1.1 North America Aquaculture Vaccines Market – Revenue and
Forecast Analysis – by Country
- 10.2.1.1 US:
North America Aquaculture Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.1.1 US: North America Aquaculture Vaccines Market Breakdown, by Type of Vaccine
- 10.2.1.1.2 US: North America Aquaculture Vaccines Market Breakdown, by Species
- 10.2.1.1.3 US: North America Aquaculture Vaccines Market Breakdown, by Route of Administration
- 10.2.1.2 Canada:
North America Aquaculture Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.2.1 Canada: North America Aquaculture Vaccines Market Breakdown, by Type of Vaccine
- 10.2.1.2.2 Canada: North America Aquaculture Vaccines Market Breakdown, by Species
- 10.2.1.2.3 Canada: North America Aquaculture Vaccines Market Breakdown, by Route of Administration
- 10.2.1.3 Mexico :
North America Aquaculture Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.3.1 Mexico : North America Aquaculture Vaccines Market Breakdown, by Type of Vaccine
- 10.2.1.3.2 Mexico : North America Aquaculture Vaccines Market Breakdown, by Species
- 10.2.1.3.3 Mexico : North America Aquaculture Vaccines Market Breakdown, by Route of Administration
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 AquaTactics Fish Health
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 HIPRA SA
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Merck & Co Inc.
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Zoetis Inc.
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Phibro Animal Health Corp
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Elanco Animal Health Inc
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations